Senores Pharmaceuticals Limited (NSE:SENORES)

Market Cap	51.16B +119.7%
Revenue (ttm)	6.33B +70.7%
Net Income	1.16B +98.7%
EPS	26.39 +63.9%
Shares Out	46.05M
PE Ratio	42.10
Forward PE	33.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	401,387
Average Volume	647,713
Open	1,112.60
Previous Close	1,109.35
Day's Range	1,093.15 - 1,130.00
52-Week Range	499.55 - 1,194.40
Beta	n/a
RSI	69.32
Earnings Date	May 14, 2026

About Senores Pharmaceuticals

Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supp...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2017
• Employees: 194
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SENORES

Financial Performance

In fiscal year 2026, Senores Pharmaceuticals's revenue was 6.80 billion, an increase of 70.67% compared to the previous year's 3.98 billion. Earnings were 1.16 billion, an increase of 98.74%.